<DOC>
	<DOCNO>NCT00219778</DOCNO>
	<brief_summary>The first indication hysterectomy France uterine leiomyoma . When symptomatic leiomyoma particularly responsables increase menstruation duration volume . Echography reference exam diagnosis . It exist two treatment way : -firstly progestatives antifibrinolytics treatment hemorragic symptom , -secondly LH-RH analog treatment leiomyoma volume hemorragic symptom use small period risk osteoporosis . Different study different dos mifepristone release . The author observe decrease leiomyomas volume . Based experience present placebo control study objective : -to confirm efficacy 10 mg oral mifepristone 24 week volume decrease symptom leiomyoma , - ass safety treatment . The aim avoid delay hysterectomy non menopausal patient . During study patient evaluate biological exam , clinical exam , echography , medical interrogation diary card .</brief_summary>
	<brief_title>A Study Efficacy 10 mg Oral Mifepristone Treatment Symptomatic Uterine Leiomyomas</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>patient willing able participate study patient write informed consent obtain patient contribute National Insurance Scheme patient age 25 49 year old non menopausal patient patient use non hormonal contraception patient one several , interstitial subserous , uterine leiomyoma echographic diameter leiomyoma must equal high 30 mm leiomyoma must symptomatic</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>